CITIGROUP INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 33 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,131,000
+1.1%
1,169,0000.0%0.00%0.0%
Q2 2022$1,119,000
-1.5%
1,169,0000.0%0.00%0.0%
Q1 2022$1,136,000
+70.6%
1,169,000
+74.7%
0.00%
Q4 2021$666,000
+311.1%
669,000
+307.9%
0.00%
Q2 2021$162,000
-4.7%
164,0000.0%0.00%
Q1 2021$170,000
+38.2%
164,000
+25.2%
0.00%
Q4 2020$123,000
-91.6%
131,000
-92.1%
0.00%
-100.0%
Q2 2020$1,457,000
+2873.5%
1,661,000
+2715.3%
0.00%
Q1 2020$49,000
+444.4%
59,000
+490.0%
0.00%
Q2 2019$9,00010,0000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders